These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31629553)

  • 21. Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide.
    Badiyan SN; Markovina S; Simpson JR; Robinson CG; DeWees T; Tran DD; Linette G; Jalalizadeh R; Dacey R; Rich KM; Chicoine MR; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):877-85. PubMed ID: 25257812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas.
    Sarria GR; Petrova V; Wenz F; Abo-Madyan Y; Sperk E; Giordano FA
    Radiat Oncol; 2020 May; 15(1):110. PubMed ID: 32410696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.
    Neidert MC; Hostettler IC; Burkhardt JK; Mohme M; Held U; Kofmehl R; Eisele G; Woernle CM; Regli L; Bozinov O
    Neurosurg Rev; 2016 Jul; 39(3):401-9. PubMed ID: 26860420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution.
    Tsung AJ; Prabhu SS; Lei X; Chern JJ; Benjamin Bekele N; Shonka NA
    J Neurooncol; 2011 Dec; 105(3):555-62. PubMed ID: 21643841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
    Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
    Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
    J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment.
    Kong XT; Nguyen NT; Choi YJ; Zhang G; Nguyen HN; Filka E; Green S; Yong WH; Liau LM; Green RM; Kaprealian T; Pope WB; Nghiemphu PL; Cloughesy T; Lassman A; Lai A
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1195-1203. PubMed ID: 29722661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
    Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
    Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
    Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.
    Inogés S; Tejada S; de Cerio AL; Gállego Pérez-Larraya J; Espinós J; Idoate MA; Domínguez PD; de Eulate RG; Aristu J; Bendandi M; Pastor F; Alonso M; Andreu E; Cardoso FP; Valle RD
    J Transl Med; 2017 May; 15(1):104. PubMed ID: 28499389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
    Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
    World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated hyperfractionation plus temozolomide in glioblastoma.
    Kaul D; Florange J; Badakhshi H; Grün A; Ghadjar P; Exner S; Budach V
    Radiat Oncol; 2016 May; 11():70. PubMed ID: 27209069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
    Doron O; Wong T; Ablyazova F; Singha S; Cavallaro J; Ben-Shalom N; D'Amico RS; Harshan M; McKeown A; Zlochower A; Langer DJ; Boockvar JA
    J Neurooncol; 2024 Jun; 168(2):225-235. PubMed ID: 38664311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebellar glioblastoma multiforme: a retrospective study of 28 patients at a single institution.
    Yang S; Liu J; Wang T; Li X; You C
    Int J Neurosci; 2013 Oct; 123(10):691-7. PubMed ID: 23550813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractionated Stereotactic Sequential Boost in a Selected Cohort of Glioblastoma Patients: A Mono-institutional Analysis.
    Marchionni A; Palumbo I; Montesi G; Bini V; Zucchetti C; Cenci N; Chiarini P; Saccia S; Aristei C; Lupattelli M
    Anticancer Res; 2020 Jun; 40(6):3387-3393. PubMed ID: 32487635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.